GATTI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 1.335
EU - Europa 540
AS - Asia 229
AF - Africa 13
SA - Sud America 6
OC - Oceania 3
Totale 2.126
Nazione #
US - Stati Uniti d'America 1.323
IT - Italia 120
UA - Ucraina 113
SE - Svezia 104
SG - Singapore 94
IN - India 70
CN - Cina 57
FI - Finlandia 48
NL - Olanda 39
GB - Regno Unito 33
DE - Germania 27
IE - Irlanda 13
TG - Togo 13
BE - Belgio 10
CA - Canada 10
RO - Romania 7
AR - Argentina 6
BG - Bulgaria 6
FR - Francia 6
RU - Federazione Russa 6
NZ - Nuova Zelanda 3
GR - Grecia 2
MX - Messico 2
PK - Pakistan 2
PL - Polonia 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CH - Svizzera 1
ES - Italia 1
IR - Iran 1
LK - Sri Lanka 1
LV - Lettonia 1
PT - Portogallo 1
Totale 2.126
Città #
Woodbridge 164
Fairfield 120
Chandler 108
Ann Arbor 100
Ashburn 82
Singapore 70
Houston 59
Dearborn 56
Wilmington 45
Seattle 43
Santa Clara 42
Jacksonville 40
Princeton 36
Plano 35
Cambridge 32
Beijing 27
Milan 23
Des Moines 20
Boston 19
Riverside 16
Boardman 15
Lawrence 15
Helsinki 14
Lomé 13
Dublin 12
San Diego 12
San Paolo di Civitate 12
Brussels 10
Maserada Sul Piave 10
Rome 10
Lendinara 9
San Mateo 9
Auburn Hills 8
Bremen 8
Fremont 8
Millbury 8
Toronto 8
Andover 7
Federal 6
Nanjing 6
New York 6
Norwalk 6
Pune 6
Sofia 6
Southend 6
Los Angeles 5
Colleferro 3
Hefei 3
Mannheim 3
Moscow 3
Nanchang 3
Parma 3
Rovigo 3
Auckland 2
Buffalo 2
Bühl 2
Chieti 2
Chongqing 2
Falkenstein 2
Falls Church 2
Frankfurt am Main 2
Islamabad 2
Ottawa 2
Santa Maria A Monte 2
Trento 2
Wilmslow 2
Xian 2
Zhengzhou 2
Baku 1
Basking Ridge 1
Berlin 1
Bern 1
Changsha 1
Coacalco 1
Colombo 1
Cork 1
Dubai 1
Guangzhou 1
Hangzhou 1
Hebei 1
Henderson 1
Jinan 1
Kiev 1
Leawood 1
Madrid 1
Mexico City 1
Nogaredo 1
Padova 1
Palermo 1
Polverara 1
Riga 1
San Francisco De Las Llagas 1
Sant'elpidio A Mare 1
Shenyang 1
Shenzhen 1
Springfield 1
Taiyuan 1
Tappahannock 1
Terni 1
Thessaloniki 1
Totale 1.455
Nome #
L’attività ossidante dei monociti circolanti è aumentata in pazienti con diabete di tipo 2 e disfunzione erettile. 165
A case of severe occult ectopic adrenocorticotropin syndrome treated with retrograde venous adrenal ablation using ethanol 119
Antioxidant treatment associated to sildenafil reduces monocyte activation an markers of endothelial damage in patients with diabetes and erectyle dysfunction. 108
Circulating monocyte oxidative activity is increased in patients with type 2 diabetes and erectile dysfunction 88
Antioxidant treatment associated to sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study 82
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. 77
Effect of insulin on airway responsiveness in patients with type 2 diabetes mellitus: A cohort study 75
Atorvastatin downregulates monocyte CD36 expression, nuclear NFkB levels and TNFalfa production in type 2 diabetes. 69
Vascular Endothelial Growth Factor plasma levels are not correlated to renal dysfunction in patients with type 2 diabetes and hypertension. 67
Cardiovascular effects of chronic sildenafil treatment in men with type 2 diabetes 67
In pazienti diabetici l’escrezione urinaria di VEGF è correlata all’albuminuria. 65
Effetti Cardiovascolari della Somministrazione in Cronico di Sildenafil in Soggetti con ?Diabete Mellito di tipo 2 65
Atorvastatin Downregulates Monocyte CD36 Expression, Nuclear NF kappa B and TNF alpha Levels in Type 2 Diabetes 65
L’attivita’ ossidante dei monociti circolanti e’ aumentata in pazienti diabetici con disfunzione erettile 63
Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects 61
Waist circumference reduction after insulin detemir therapy in type 2 diabetes patients previously treated with NPH 60
Prevalenza di bassi livelli di colesterolo HDL e correlazione con il grado di controllo glicometabolico in pazienti con diabete di tipo 2. 58
Poor Glycemic Control Is an Independent Risk Factor for Low HDL Cholesterol in Patients With Type 2 Diabetes 58
Poly(ADP-ribose)polymerase activity is reduced in circulating mononuclear cells from type 2 diabetic patients 58
Aumentata espressione di poly-ADP ribosio polymerasi in mononucleati circolanti di pazienti con diabete di tipo 2 57
Atorvastatin downregulates monocyte CD36 scavenger receptor expression and nuclear NFkB levels in type 2 diabetic patients. 55
Phenotyping normal kidney function in elderly patients with type 2 diabetes: a cross-sectional multicentre study 54
The metabolic syndrome and insulin resistance are not risk factors for chronic kidney disease in obese non diabetic subjects. 53
Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2 53
The metabolic sindrome is not a risk factor for reduced kidney function in obese non diabetic subjects. 50
Waist circumference reduction after insulin Detemir therapy in type 2 diabetes patients previously treated with NPH. 48
Identificazione e caratterizzazione di proteine poly(ADP-ribosil)ate in mononucleati circolanti di diabetici di tipo 2 mediante proteomica. 47
Lack of the QTc physiologic decrease during cardiac stress test in patients with type 2 diabetes treated with secretagogues 44
Sindrome metabolica e disfunzione erettile in una popolazione di pazienti obesi non diabetici. 42
The impairment of renal function is not associated to altered circulating vascular endothelial growth factor in patients with Type 2 diabetes and hypertension. 42
Does intervention on glycemic control influence HDL cholesterol levels in type 2 diabetes? A pilot study 36
La disfunzione erettile e i disturbi sessuali nel diabete 35
Effetti del trattamento con atorvastatina sull'espressione del CD36 e sui livelli di NFkB nucleare in monociti circolanti di pazienti con diabete di tipo 2. 32
Angiotensin blockade and matrix synthesis by glomerular epithelial cells in high glucose: A further experimental insight into the pathophysiology of diabetic nephropathy 30
VENTRICULAR REMODELING IN PATIENTS WITH TYPE 2 DIABETES AND HYPERTENSION: ROLE OF VEGF. 27
Totale 2.175
Categoria #
all - tutte 5.915
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.915


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020284 0 0 0 0 0 89 56 47 36 32 15 9
2020/2021209 21 17 4 12 4 23 40 12 17 22 32 5
2021/2022371 9 21 38 21 48 14 6 28 25 29 69 63
2022/2023401 77 58 30 42 50 58 11 13 43 0 19 0
2023/2024176 15 26 3 13 18 35 1 19 2 14 10 20
2024/2025173 39 12 45 9 32 36 0 0 0 0 0 0
Totale 2.175